BUY Suven Life Sciences Limited — Sumeet Bagadia, Choice Broking
bySumeet Bagadia, Choice BrokingHorizon: NA (inferred Swing (≤2wk))11 Aug 2026via LiveMint Markets
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Nothing found in this tip’s window yet.
Suven Life Sciences Ltd announced its un-audited financial results for the quarter ended June 30, 2026. The results were reviewed by the audit committee and approved by the Board of Directors.
BSE · Board Meeting·6 Aug · 2w ago
Suven Life Sciences Limited announced its un-audited financial results for the quarter ended June 30, 2026. The results were reviewed by the audit committee and approved by the Board of Directors.
NSE · Outcome of Board Meeting·6 Aug · 2w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Suven Life Sciences
- BUY — Pankaj Randad15 Oct 2026 · ~2 weeks · target ₹330 · SL hit
- BUY — Nilesh Jain, Centrum Broking24 Aug 2026 · ~3 months · target ₹390 · Target hit
- BUY — Sumeet Bagadia, Choice Broking17 Aug 2026 · ~2 weeks · target ₹370 · Target hit
More from Sumeet Bagadia, Choice Broking
- BUY Union Bank of India22 Oct 2026 · ~2 weeks · target ₹192 · Active
- BUY Coforge22 Oct 2026 · Same day · target ₹1,980 · Target hit
- BUY NHPC21 Oct 2026 · ~2 weeks · target ₹75 · Active
- BUY Titan Company20 Oct 2026 · ~3 months · target ₹4,860 · Active
- BUY The Jammu & Kashmir Bank19 Oct 2026 · ~2 weeks · target ₹146 · Active

